TLDR Oracle stock is down roughly 29% year-to-date as of early April 2026, despite strong revenue growth. Q3 FY26 revenue came in at $17.2 billion, up 22% year-TLDR Oracle stock is down roughly 29% year-to-date as of early April 2026, despite strong revenue growth. Q3 FY26 revenue came in at $17.2 billion, up 22% year-

Oracle (ORCL) Stock Falls 29% While Revenue Soars — Time to Buy the Dip?

2026/04/13 16:18
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Oracle stock is down roughly 29% year-to-date as of early April 2026, despite strong revenue growth.
  • Q3 FY26 revenue came in at $17.2 billion, up 22% year-over-year, beating Wall Street estimates.
  • Oracle’s remaining performance obligations (RPO) backlog surged to $553 billion, up from $455 billion in September 2025.
  • The company plans to spend $50 billion on capital expenditure in FY2026 and raise another $50 billion through debt and equity.
  • Analyst opinion is split, with price targets ranging from $160 to $400, reflecting deep disagreement over the timeline to free cash flow.

Oracle’s stock has been one of the more puzzling stories on Wall Street this year. The numbers look strong on the surface — revenue is growing fast, the backlog is enormous — but the stock has shed nearly a third of its value since January. Something doesn’t add up, and that’s exactly what has analysts arguing.


ORCL Stock Card
Oracle Corporation, ORCL

The company reported fiscal Q3 FY26 revenue of $17.2 billion, up 21.7% from a year earlier and ahead of analyst expectations of $16.91 billion. Earnings per share came in at $1.79, beating the consensus of $1.71. Oracle also lifted its fiscal 2027 revenue target to $90 billion.

The backlog tells an even bigger story. Remaining performance obligations climbed to $553 billion by March 2026, up sharply from $455 billion just six months earlier. That’s a lot of contracted future revenue.

So what’s the problem?

The Cost of Growing Fast

Oracle has said it expects fiscal 2026 capital expenditure of $50 billion — more than double the prior year. The company also said it plans to raise an additional $50 billion through debt and equity to fund cloud capacity expansion. By December 2025, Oracle already carried around $100 billion in debt.

That’s a heavy load. And investors are watching cash flows closely, knowing the returns from these investments won’t arrive overnight.

Melius analyst Ben Reitzes cut the stock to Hold in February with a $160 price target, arguing that Oracle should be valued more like an infrastructure company than a software firm — because without meaningful free cash flow until the 2030s, the usual software premium doesn’t hold.

Adding to the pressure, Oracle announced roughly 30,000 layoffs via mass email, a move that may trim near-term costs but raised questions about execution and morale.

Where Bulls and Bears Stand

Not everyone sees it that way. JPMorgan upgraded Oracle to Overweight in March with a $210 price target, calling the selloff “drastic” and arguing it improved the risk-reward more than the business had actually changed.

Mizuho analyst Siti Panigrahi kept a Buy rating but trimmed her price target from $400 to $320, pointing to Oracle’s cloud infrastructure as difficult for rivals to replicate. She also noted a shift in enterprise AI adoption — businesses want to bring AI to their existing data rather than move data to new platforms, a dynamic that plays to Oracle’s strengths.

KeyBanc’s Jackson Ader maintained an Overweight rating with a $300 target, calling Oracle a broad AI play across infrastructure, applications, and data layers. The company’s new Fusion Agentic Applications — targeting finance, HR, supply chain, and customer experience — are central to that story.

On the insider side, EVP Douglas Kehring sold 35,000 shares in January at around $194.89, reducing his ownership by roughly 51%. CEO Clayton Magouyrk sold 10,000 shares in February at $155.23. Corporate insiders collectively own 40.9% of the stock.

As of early April, ORCL opened at $138.00, well below its 52-week high of $345.72 and approaching its 52-week low of $121.24. The consensus analyst price target sits at $260.71, implying substantial upside — if the bulls are right about the timeline.

The post Oracle (ORCL) Stock Falls 29% While Revenue Soars — Time to Buy the Dip? appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55
Zelenskyy warns Russia aims to involve Belarus in Ukraine conflict

Zelenskyy warns Russia aims to involve Belarus in Ukraine conflict

The post Zelenskyy warns Russia aims to involve Belarus in Ukraine conflict appeared on BitcoinEthereumNews.com. Zelenskyy said Russia is trying to draw Belarus
Share
BitcoinEthereumNews2026/04/18 11:12
Bitcoin, Gold, and U.S. Stocks Dive as Trump Pledges to Hit Iran ‘Extremely Hard’

Bitcoin, Gold, and U.S. Stocks Dive as Trump Pledges to Hit Iran ‘Extremely Hard’

The post Bitcoin, Gold, and U.S. Stocks Dive as Trump Pledges to Hit Iran ‘Extremely Hard’ appeared on BitcoinEthereumNews.com. In brief Bitcoin dropped Thursday
Share
BitcoinEthereumNews2026/04/02 17:57

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!